Search clinical trials for: citalopram and escitalopram

Total 272550 results

Hoffmann-La Roche

Completed

A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers

Healthy Volunteer

United States
Linkoeping University

Completed

Serum Concentrations of Antidepressant Drugs in Pregnant Women - a Naturalistic Study (PAPA)

Pregnancy | Pharmacokinetics | Antidepressive Agents

Sweden
University of Oxford

Recruiting

REward Processing And Citalopram Study (REPAC)

Anhedonia

United Kingdom
University of Michigan
National Institute on Aging (NIA)

Active, not recruiting

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Parkinson Disease

United States
Hoffmann-La Roche

Completed

A Study of RO4995819 in Combination With Citalopram in Healthy Volunteers

Healthy Volunteer

France
University of Texas Southwestern Medical Center

Terminated

Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression (PRECISE-D)

Depression

United States
Massachusetts General Hospital

Terminated

Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms (Seroquel)

Major Depressive Disorder With Psychotic Features

United States
University Health Network, Toronto
GlaxoSmithKline; H. Lundbeck A/S

Completed

Memory Functioning and Antidepressant Treatment

Depression | Major Depressive Disorder

Canada
Nanjing Medical University

Unknown

Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder

Major Depressive Disorder

China
Mclean Hospital

Completed

Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression

Major Depressive Disorder | MDD | Citalopram

United States
Ontario Neurotrauma Foundation

Unknown

Antidepressant Maintenance in Traumatic Brain Injury

Depression

Canada
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

Depression

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

The ISLAND Study: InSuLa Assessed Needs for Depression (ISLAND)

Depression

United States
Targacept Inc.

Completed

TC-5214 as add-on the Treatment of Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India
University of British Columbia

Not yet recruiting

Human Cerebral Blood Flow and Serotonin

Depression | Serotonin Deficiency

Canada
Taipei Veterans General Hospital, Taiwan
National Tsing Hua University,Taiwan

Completed

Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer (BNCT)

Head and Neck Cancer

Taiwan
Boston University

Completed

Effect of Creatine and L-Arginine on Endothelial Function

Coronary Artery Disease
Rotman Research Institute at Baycrest
Centre for Addiction and Mental Health; University of Toronto

Terminated

Effects of Intravenous (IV) Citalopram on Emotional Brain Activity in Healthy Young and Elderly Adults

Healthy Young and Elderly Volunteers

Canada
Universitaire Ziekenhuizen KU Leuven

Unknown

Citalopram for Reflux Hypersensitivity and Functional Heartburn

GERD

Belgium
Vrije Universiteit Brussel
University Hospital, Antwerp; Universiteit Antwerpen; Research Foundation Flanders and other collaborators

Unknown

Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes

Arthritis, Rheumatoid | Fibromyalgia | Fatigue Syndrome, Chronic

Belgium
Queen's University
H. Lundbeck A/S

Completed

Specific Effects of Escitalopram on Neuroendocrine Response

Healthy

Canada
Helsinki University Central Hospital

Unknown

PCV13 + Hepatitis A Vaccine for Adults (PCV13+HepA)

Measurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis A

Finland, Sweden
Emory University
National Institute of Mental Health (NIMH)

Completed

Identifying Factors That Predict Antidepressant Treatment Response

Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults

Major Depressive Disorder | Dysthymic Disorder | Depressive Disorder, NOS

United States
Bristol-Myers Squibb

Completed

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Depression

Italy, South Africa, United States, Australia, Argentina, Canada, Austria, France, Spain, India, Puerto Rico, United Kingdom
Eli Lilly and Company

Completed

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

Major Depressive Disorder

Denmark, France, Greece, Hungary, Italy, Netherlands, Romania, Slovenia, Spain, Sweden, Turkey
Federico II University

Recruiting

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Burning Mouth Syndrome

Italy
Ciusss de L'Est de l'Île de Montréal

Completed

Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders (CRY-MOOD)

Major Depressive Disorder

Canada
National Institute on Drug Abuse (NIDA)

Completed

Serotonin, Impulsivity, and Cocaine Dependence Treatment

Cocaine Dependence

United States
University of Iowa
Mayo Clinic; National Institute of Neurological Disorders and Stroke (NINDS); University of Rochester and other collaborators

Completed

Citalopram to Enhance Cognition in HD (CIT-HD)

Huntington Disease | Chorea | Executive Dysfunction

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Functional Dyspepsia Treatment Trial (FDTT)

Dyspepsia and Other Specified Disorders of Function of Stomach

United States, Canada
Vanderbilt University Medical Center

Completed

Connectivity Affecting the Antidepressant REsponse Study (CAARE)

Major Depressive Disorder

United States
Capital Medical University

Completed

Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD (SCE)

Major Depressive Disorder

China
US Department of Veterans Affairs

Completed

VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients

Depression | Hepatitis C

United States
Oleg Levada

Unknown

Cognitive Dysfunction in MDD Patients

Major Depressive Disorder

Ukraine
Hillerod Hospital, Denmark

Terminated

Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7) (DUAG-7)

Major Depression

Denmark
Takeda

Completed

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Treatment Outcome

United States, Canada
Massachusetts General Hospital
Medtronic - MITG

Completed

Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression

Major Depressive Disorder
New York State Psychiatric Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

Major Depressive Disorder | Alcohol Use Disorder

United States
Azienda Ospedaliera Universitaria Integrata Verona
University of Catania

Completed

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment (VESPA)

Major Depressive Disorder

Italy
The Alfred

Terminated

Investigation of Tibolone and Escitalopram in Perimenopausal Depression

Perimenopausal Depression

Australia
Sunnybrook Health Sciences Centre
Obsessive Compulsive Foundation; Centre for Addiction and Mental Health

Completed

Predicting Medication Response in Obsessive Compulsive Disorder

Obsessive Compulsive Disorder

Canada
Kalaco Scientific, Inc.

Completed

Nexalin Therapy for the Treatment of Depressive Symptoms

Depression

Russian Federation
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Characteristics of Sleep Patterns in Young Adults With and Without Insomnia

Sleep Disorders

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Depression | Breast Cancer | Hot Flashes | Psychosocial Effects of Cancer and Its Treatment

United States
Hunan Province Tumor Hospital

Recruiting

Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer (CREATE)

Non Small Cell Lung Cancer

China
Shanghai Municipal Hospital of Traditional Chinese...
Shanghai Mental Health Center; Xuhui Central Hospital, Shanghai; Shanghai Huangpu...

Recruiting

Effect of Electroacupuncture on Treating the First-episode Depression

Depression

China
University of Cincinnati
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)

Alcoholism | Alcohol Abuse

United States
University of Michigan
National Institute of Neurological Disorders and Stroke (NINDS); National Center...

Recruiting

Home Transcutaneous Electrical Acustimulation (TEA) (Home-TEA)

Irritable Bowel Syndrome With Constipation

United States
Hoffmann-La Roche

Completed

A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers

Healthy Volunteer

United States

Search clinical trials for: citalopram and escitalopram

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations